Catalyst Wire Dossier Catalyst Wire Dossier

Cyclosporine ophthalmic emulsion 0.05% (PROSE device delivery)

cyclosporine ophthalmic emulsion 0.05%
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cyclosporine ophthalmic emulsion 0.05% (PROSE device delivery), covering 2025-01-13 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% in a PROSE Device [Phase 1, Phase 2]

See pricing